Development of Novel Peptidomimetics Containing a Vinyl Sulfone Moiety as Proteasome Inhibitors (Q58862067)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21506279%20AND%20SRC:MED&resulttype=core&format=json

29 January 2020

title

Development of novel peptidomimetics containing a vinyl sulfone moiety as proteasome inhibitors (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21506279%20AND%20SRC:MED&resulttype=core&format=json

29 January 2020

0 references

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21506279%20AND%20SRC:MED&resulttype=core&format=json

29 January 2020

Nicola Micale

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21506279%20AND%20SRC:MED&resulttype=core&format=json

29 January 2020

Tanja Schirmeister

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21506279%20AND%20SRC:MED&resulttype=core&format=json

29 January 2020

Silvana Grasso

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21506279%20AND%20SRC:MED&resulttype=core&format=json

29 January 2020

Maria Zappala'

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21506279%20AND%20SRC:MED&resulttype=core&format=json

29 January 2020

author name string

Cinzia Bonaccorso

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21506279%20AND%20SRC:MED&resulttype=core&format=json

29 January 2020

Cornelia Heindl

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21506279%20AND%20SRC:MED&resulttype=core&format=json

29 January 2020

Maria Luisa Calabrò

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21506279%20AND%20SRC:MED&resulttype=core&format=json

29 January 2020

publication date

19 April 2011

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21506279%20AND%20SRC:MED&resulttype=core&format=json

29 January 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21506279%20AND%20SRC:MED&resulttype=core&format=json

29 January 2020

volume

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21506279%20AND%20SRC:MED&resulttype=core&format=json

29 January 2020

issue

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21506279%20AND%20SRC:MED&resulttype=core&format=json

29 January 2020

page(s)

1228-1237

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21506279%20AND%20SRC:MED&resulttype=core&format=json

Proteasomes: machines for all reasons

29 January 2020

cites work

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.201100093

Intracellular protein degradation: from a vague idea, through the lysosome and the ubiquitin-proteasome system, and onto human diseases and drug targeting (Nobel lecture).

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.201100093

Functions of the proteasome: from protein degradation and immune surveillance to cancer therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.201100093

A gated channel into the proteasome core particle

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.201100093

The base of the proteasome regulatory particle exhibits chaperone-like activity

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.201100093

Structure of 20S proteasome from yeast at 2.4 A resolution

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.201100093

20S proteasome and its inhibitors: crystallographic knowledge for drug development

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.201100093

Probing structural determinants distal to the site of hydrolysis that control substrate specificity of the 20S proteasome.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.201100093

Molecular machines for protein degradation

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.201100093

Proteasome inhibitors: poisons and remedies

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.201100093

Bortezomib (Velcadetrade mark) in the Treatment of Multiple Myeloma

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.201100093

Substrate binding and sequence preference of the proteasome revealed by active-site-directed affinity probes

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.201100093

Extended peptide-based inhibitors efficiently target the proteasome and reveal overlapping specificities of the catalytic beta-subunits

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.201100093

Global analysis of proteasomal substrate specificity using positional-scanning libraries of covalent inhibitors.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.201100093

Covalent modification of the active site threonine of proteasomal beta subunits and the Escherichia coli homolog HslV by a new class of inhibitors

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.201100093

Stereoselective beta-hydroxy-alpha-amino acid synthesis via an ether-directed, palladium-catalysed aza-Claisen rearrangement

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.201100093

Chloro-substituted Hoveyda–Grubbs ruthenium carbene: Investigation of electronic effects

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.201100093

Proteasome inhibitors: Dozens of molecules and still counting.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.201100093

Recognition of misfolding proteins by PA700, the regulatory subcomplex of the 26 S proteasome

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.201100093

inferred from DOI database lookup

7 January 2021

based on heuristic

Two-directional cross-metathesis

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.201100093

inferred from DOI database lookup

7 January 2021

based on heuristic

Aziridide-Based Inhibitors of Cathepsin L: Synthesis, Inhibition Activity, and Docking Studies

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.201100093

inferred from DOI database lookup

7 January 2021

based on heuristic

Identifiers

DOI

10.1002/CMDC.201100093

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21506279%20AND%20SRC:MED&resulttype=core&format=json

29 January 2020

1 reference